149 related articles for article (PubMed ID: 27894117)
1. t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.
Sheng G; Zeng Z; Pan J; Wang Q; Yao H; Wen L; Ma L; Wu D; Chen S
Acta Haematol; 2017; 137(1):40-43. PubMed ID: 27894117
[No Abstract] [Full Text] [Related]
2. The t(1;9)(p34;q34) fusing ABL1 with SFPQ, a pre-mRNA processing gene, is recurrent in acute lymphoblastic leukemias.
Duhoux FP; Auger N; De Wilde S; Wittnebel S; Ameye G; Bahloula K; Van den Berg C; Libouton JM; Saussoy P; Grand FH; Demoulin JB; Poirel HA
Leuk Res; 2011 Jul; 35(7):e114-7. PubMed ID: 21388681
[No Abstract] [Full Text] [Related]
3. SFPQ-ABL1-positive B-cell precursor acute lymphoblastic leukemias.
Biloglav A; Olsson-Arvidsson L; Theander J; Behrendtz M; Castor A; Johansson B
Genes Chromosomes Cancer; 2020 Sep; 59(9):540-543. PubMed ID: 32306475
[TBL] [Abstract][Full Text] [Related]
4. A new partner gene fused to ABL1 in a t(1;9)(q24;q34)-associated B-cell acute lymphoblastic leukemia.
De Braekeleer E; Douet-Guilbert N; Le Bris MJ; Berthou C; Morel F; De Braekeleer M
Leukemia; 2007 Oct; 21(10):2220-1. PubMed ID: 17541395
[No Abstract] [Full Text] [Related]
5. Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia.
Ernst T; Score J; Deininger M; Hidalgo-Curtis C; Lackie P; Ershler WB; Goldman JM; Cross NC; Grand F
Br J Haematol; 2011 Apr; 153(1):43-6. PubMed ID: 21391972
[TBL] [Abstract][Full Text] [Related]
6. SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.
Mu Q; Guo L; Hu Y; Sheng L; Zhang Y; Wu N; Chen Y; Shi C; Shi S; Wu Y; Ouyang G
Leuk Lymphoma; 2017 Sep; 58(9):1-3. PubMed ID: 28278724
[No Abstract] [Full Text] [Related]
7. Chromosomal translocation t(1;9)(q24;q34) in acute lymphoblastic leukemia patient involving the ABL1 gene.
Zámečníkova A
Leuk Res; 2011 Sep; 35(9):e149-50. PubMed ID: 21641035
[No Abstract] [Full Text] [Related]
8. Acute lymphoblastic leukemia associated with RCSD1-ABL1 novel fusion gene has a distinct gene expression profile from BCR-ABL1 fusion.
De Braekeleer E; Douet-Guilbert N; Guardiola P; Rowe D; Mustjoki S; Zamecnikova A; Al Bahar S; Jaramillo G; Berthou C; Bown N; Porkka K; Ochoa C; De Braekeleer M
Leukemia; 2013 Jun; 27(6):1422-4. PubMed ID: 23168614
[No Abstract] [Full Text] [Related]
9. Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with
Frech M; Jehn LB; Stabla K; Mielke S; Steffen B; Einsele H; Metzelder SK; Neubauer A
Haematologica; 2017 Apr; 102(4):e160-e162. PubMed ID: 28057740
[No Abstract] [Full Text] [Related]
10. NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors.
Duployez N; Grzych G; Ducourneau B; Alarcon Fuentes M; Grardel N; Boyer T; Abou Chahla W; Bruno B; Nelken B; Clappier E; Preudhomme C
Haematologica; 2016 Apr; 101(4):e133-4. PubMed ID: 26681761
[No Abstract] [Full Text] [Related]
11. Fusion of ZMIZ1 to ABL1 in a B-cell acute lymphoblastic leukaemia with a t(9;10)(q34;q22.3) translocation.
Soler G; Radford-Weiss I; Ben-Abdelali R; Mahlaoui N; Ponceau JF; Macintyre EA; Vekemans M; Bernard OA; Romana SP
Leukemia; 2008 Jun; 22(6):1278-80. PubMed ID: 18007576
[No Abstract] [Full Text] [Related]
12. A cryptic ETV6/ABL1 rearrangement represents a unique fluorescence in situ hybridization signal pattern in a patient with B acute lymphoblastic leukemia.
Song JS; Shin SY; Lee ST; Kim HJ; Kim SH
Ann Lab Med; 2014 Nov; 34(6):475-7. PubMed ID: 25368826
[No Abstract] [Full Text] [Related]
13. Thinking outside of ABL1 for resistance to tyrosine kinase inhibitors: a perspective of the SEPT9-ABL1 fusion protein.
Hu T; Ciccarelli BT
Leuk Res; 2014 Dec; 38(12):1399-400. PubMed ID: 25449686
[No Abstract] [Full Text] [Related]
14. t(12;17)(p13;q12)/TAF15-ZNF384 Rearrangement in Acute Lymphoblastic Leukemia.
Kim J; Kim HS; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 Jul; 36(4):396-8. PubMed ID: 27139620
[No Abstract] [Full Text] [Related]
15. Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.
Masuzawa A; Kiyotani C; Osumi T; Shioda Y; Iijima K; Tomita O; Nakabayashi K; Oboki K; Yasuda K; Sakamoto H; Ichikawa H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Mori T
Eur J Haematol; 2014 Mar; 92(3):263-7. PubMed ID: 24215620
[TBL] [Abstract][Full Text] [Related]
16. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
Deucher AM; Qi Z; Yu J; George TI; Etzell JE
Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
[TBL] [Abstract][Full Text] [Related]
17. Lymphoblastic lymphoma with mature b-cell immunophenotype and MLL-AF9 in a child.
Takachi T; Iwabuchi H; Imamura M; Imai C
Pediatr Blood Cancer; 2011 Dec; 57(7):1251-2. PubMed ID: 21681937
[No Abstract] [Full Text] [Related]
18. Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2).
Yamamoto K; Yakushijin K; Nakamachi Y; Miyata Y; Sanada Y; Tanaka Y; Okamura A; Kawano S; Hayashi Y; Matsuoka H; Minami H
Ann Hematol; 2014 Aug; 93(8):1435-8. PubMed ID: 24318592
[No Abstract] [Full Text] [Related]
19. Biphenotypic lymphoblastic non-Hodgkin lymphoma with a balanced translocation t(1;9)(p10;q10): unusual presentation with poor outcome.
Chan GC; Ma SK; Ha SY; Sriastava G; Wan TS; Kwong DL; Chan LC; Lau YL
Med Pediatr Oncol; 1999 Jun; 32(6):450-2. PubMed ID: 10358707
[No Abstract] [Full Text] [Related]
20. A novel three-way Ph variant t(8;9;22) in adult acute lymphoblastic leukemia.
Cho SY; Kim SY; Jeon YL; Oh SH; Cho EH; Lee WI; Cho KS; Park TS
Ann Clin Lab Sci; 2011; 41(1):71-8. PubMed ID: 21325259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
